Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized ...
4d
MedPage Today on MSNSimilar BPH Symptom Relief With Aquablation, Laser EnucleationBaseline symptom scores decreased by 11-12 points at 3 months with aquablation and transurethral laser enucleation of the ...
8d
News-Medical.Net on MSNAquablation shows promise for treating enlarged prostate with fewer side effectsUsing a high-pressure water jet to operate on an enlarged prostate can better preserve the ability to ejaculate, compared ...
Teleflex today announced new data highlighting the success of its UroLift benign prostatic hyperplasia (BPH) treatment system ...
Teleflex (TFX) announced that new findings from the CLEAR study were presented at the 40th Annual European Association of Urology Congress in ...
A new Global Urological Device Market Report offers critical insights for CEOs, CFOs, product and marketing managers in the ...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from ...
obstruction recurred and the catheter was replaced. Patient 1 had a history of nocturia and dysuria. Results of prior transrectal ultrasound (TRUS) revealed a 92.8-g prostate. Patient 2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results